New York Based Fortress Biotech, Inc. Participate in Virtual Conference

New York based Fortress Biotech Inc will participate in three virtual investor conferences in June 2021.The  Biotech is an innovative biopharmaceutical company which was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.

Depending on the revenue growth over three-year periods. Fortress Biotech Inc focuses on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.

Fortress Biotech Inc consists of seven marketed prescription pharmaceutical products. Nearly 25 programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy, which allow it to create value for shareholders. It advances its diversified pipeline through a streamlined operating configuration that enables profitable drug development.

The event is Summer Solstice Best Ideas from the Buy Side Virtual Conference. The company will present on Wednesday, June 2, 2021, at 1:00 p.m. ET and will participate in one-on-one meetings during the conference. A webcast of the presentation will be available on the Events page under the News & Media section of Fortress’ website.  The company will present on Wednesday, June 9, 2021 at 2:00 p.m. ET.At the Raymond James Human Health Innovation Virtual Conference, the company will present on Tuesday, June 22, 2021, at 3:20 p.m. ET and will participate in one-on-one meetings during the conference.